Two types of monocytes, Ly6C hi and Ly6C lo , infiltrate the heart in murine experimental autoimmune myocarditis (EAM). We discovered a role for cardiac fibroblasts in facilitating monocyte-to-macrophage differentiation of both Ly6C hi and Ly6C lo cells, allowing these macrophages to perform divergent functions in myocarditis progression. During the acute phase of This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
EAM, IL-17A is highly abundant. It signals through cardiac fibroblasts to attenuate efferocytosis of Ly6C hi monocyte-derived macrophages (MDMs) and simultaneously prevents Ly6C lo monocyte-to-macrophage differentiation. We demonstrated an inverse clinical correlation between heart IL-17A levels and efferocytic receptor expressions in humans with heart failure (HF). In the absence of IL-17A signaling, Ly6C hi MDMs act as robust phagocytes and are less proinflammatory, whereas Ly6C lo monocytes resume their differentiation into MHCII + macrophages. We propose that MHCII + Ly6C lo MDMs are associated with the reduction of cardiac fibrosis and prevention of the myocarditis sequalae.
INTRODUCTION
Myocarditis remains a leading cause of heart failure (HF) in children and young adults (Caforio et al., 2013a; Dimas et al., 2009) . A recent global estimate of myocarditis incidence is approximately 1.5-million cases annually (Kang and An, 2018) . However, the actual myocarditis incidence could be significantly underestimated due to the heterogeneous clinical manifestations and a wide spectrum of disease presentations (Fung et al., 2016) . Between 9% and 16% of patients with myocarditis develop dilated cardiomyopathy (DCM). Yet no biomarkers are currently available to identify myocarditis patients at risk of developing DCM (Fairweather et al., 2014; Hochholzer et al., 2010; Mason et al., 1995) . To date, treatment of myocarditis and prevention of its sequelae, DCM, remain vital goals in the quest to reduce morbidity and mortality in patients.
In the experimental autoimmune myocarditis (EAM) model as well as human clinical studies, we and others have reported that monocytes and macrophages comprise approximately three-quarters of the infiltrating cells in the injured myocardium (Barin et al., 2012; Theaker et al., 1985) . Cardiac tissue-resident macrophages originate from precursors that develop in the embryonic yolk sac and fetal liver and maintain locally as self-renewing populations to perform tissue-specific functions. After birth, a proportion of embryonically derived cardiacresident macrophages are progressively replaced by monocyte-derived macrophages (MDMs) that originate in the bone marrow (BM) Guilliams et al., 2014; Hashimoto et al., 2013; Molawi et al., 2014; Schulz et al., 2012; Yona et al., 2013) . BM-derived circulating monocytes in mice consist of two subsets: the "classical" inflammatory Ly6C hi monocytes and the "non-classical" patrolling Ly6C lo monocytes. The former resemble human CD14 hi CD16 − and/or CD14 + CD16 + monocytes, while the latter have similar characteristics to human CD14 − CD16 hi monocytes (Carlin et al., 2013; Geissmann et al., 2003; Gordon and Taylor, 2005; Ingersoll et al., 2010; Jakubzick et al., 2013; Shi and Pamer, 2011; Sunderkötter et al., 2004; Ziegler-Heitbrock, 2007) . Cardiac injury triggers massive Ly6C hi monocytes mobilization, trafficking, and extravasation into the heart, where they promote inflammation associated with tissue repair and remodeling (Bronte and Pittet, 2013; Dutta et al., 2012; Leuschner et al., 2012; Robbins et al., 2012; Epelman et al., 2014; Heidt et al., 2014; Hilgendorf et al., 2014) .
It is challenging to distinguish tissue-resident macrophages from recruited MDMs when they co-exist in the same inflammatory niche. Ly6C hi monocytes are known precursors to cardiac macrophages during cardiac injury Nahrendorf et al., 2007) . However, the contribution of patrolling Ly6C lo monocytes to the macrophage pool is controversial. Ablation of Ly6C lo monocytes in a mouse model of myocardial infarction (MI) resulted in depletion of other monocyte and macrophage populations (Nahrendorf et al., 2007) . Moreover, it is unclear whether the phenotype and function of either Ly6C hi or Ly6C lo MDMs differ from one another. The mechanism through which extrinsic stimuli influence monocytes survival, proliferation, differentiation, and function in the context of cardiac damage and inflammation is not understood.
To better understand the underlying mechanisms of how recruited monocytes drive DCM, we fate-mapped the accumulating monocyte subsets in the heart during myocardial inflammation. We found that IL-17A-activated cardiac fibroblasts significantly arrested Ly6C lo monocyte-to-macrophage differentiation and proliferation. We also discovered that IL-17A signaling through cardiac fibroblasts can downregulate efferocytosis receptors expressed by Ly6C hi MDMs, negatively affecting their phagocytic function during inflammation resolution. Furthermore, both intrinsic and extrinsic factors modulate distinct transcriptomic profiles of Ly6C hi and Ly6C lo MDMs, signifying their potential functional differences in the context of myocarditis. Our work provides evidence that cardiac fibroblasts play a decisive role in MDM ontogeny and function during cardiac injury. Our findings provide insights into monocyte and macrophage biology and their roles in the context of chronic cardiac inflammation.
RESULTS

Infiltrating Monocytes Contribute to Three Subsets of Macrophages during Myocarditis
We created parabiotic mice to elucidate the contribution of infiltrating monocytes to cardiac macrophage populations during myocarditis development. The circulations of CD45.1 and CD45.2 mice were surgically joined, and EAM was induced in CD45.1 mice 2 days prior to parabiosis ( Figure 1A ). On day 21 of EAM, we confirmed by histology that only CD45.1 parabionts developed severe myocardium infiltration ( Figure 1B ). Flow cytometric analysis showed a significantly elevated total number of infiltrating non-neutrophilic myeloid cells in the CD45.1 EAM hearts compared to their CD45.2 parabiotic partners ( Figure 1C ). We also observed that CD45.1 EAM hearts had more total F4/80 hi CD64 + macrophages compared to non-EAM CD45.2 hearts, indicating cardiac macrophage expansion in response to inflammation ( Figure 1D ). We found a higher frequency of CD45.2 + MDMs in the CD45.1 EAM mice, compared to CD45.1 + MDMs in the CD45.2 non-EAM mice (Figures 1E and 1F ; see the gating strategy in Figure S1A ). However, a higher frequency of CD45.2 + MDMs in the CD45.1 EAM mice did not reflect the increase in infiltrating monocyte populations ( Figure 1E ). In addition, the heart Ly6C hi -to-Ly6C lo monocyte ratio between parabionts did not differ significantly ( Figure 1G ). Resident tissue macrophages can be further divided into three subsets, based on their expressions of CCR2 and MHCII . We found that infiltrating CD45.2 + monocytes predominantly differentiated into CCR2 + MHCII + macrophages, though they possess the capacity to replenish all three macrophage subsets in the EAM hearts ( Figures 1E and 1H ). However, the heart-infiltrating CD45.1 + monocytes in the non-EAM CD45.2 mice differentiated only into MHCII + macrophages (Figures 1E and 1H) . Taken together, our data support the idea that during cardiac inflammation infiltrating monocytes readily differentiate into macrophages and these monocyte-derived cells can replenish all three macrophage subpopulations.
During cardiac inflammation, mature Ly6C hi monocytes arise from common monocyte progenitors (cMoPs) in the BM before trafficking to the heart (Hettinger et al., 2013) . We examined the mature monocyte population in the BM in response to cardiac inflammation (see the gating strategy in Figure S1B ). We found a substantial presence of CD45.1 + -grafted cells in the CD45.2 parabiont BM, whereas CD45.2 + monocytes were relatively rare in the CD45.1 EAM parabiont BM (Figures S1C and S1D). We speculated that this could be due to undifferentiated CD45.1 + Ly6C hi monocytes homing back to the CD45.1 BM in the absence of inflammation (Sunderkötter et al., 2004) . Alternatively, a systemic response to adjuvants used for EAM induction in CD45.1 + parabionts could increase monocyte infiltration into non-EAM parabiont BM. Another possible explanation is that EAM BM is saturated with inflammatory cells, which prevented CD45.2 + monocytes from infiltrating CD45.1 BM. Nevertheless, the ratio of Ly6C hi -to-Ly6C lo monocytes was highly comparable between parabionts in the BM ( Figure S1E ). Collectively, the similarity of monocyte ratios in the BM between EAM and naive mice suggests the local cardiac inflammatory milieu is instrumental in monocyte-to-macrophage differentiation in the heart.
Cardiac Fibroblasts Facilitate Ly6C hi and Ly6C lo Monocyte-to-Macrophage Differentiation
The results from the parabiosis experiments suggested that MDMs in an inflamed cardiac environment are a highly heterogenous population. Whether macrophage heterogeneity is instigated by monocyte intrinsic differences and/or extrinsic environmental factors is not yet known. Cardiac fibroblasts play a key sentinel role during myocarditis as they produce myelotropic chemokines and cytokines such as GM-CSF and CCL2 (Baldeviano et al., 2010; Wu et al., 2014) . This immune modulatory property of cardiac fibroblasts was also confirmed in MI and Kawasaki disease (Amoah et al., 2015; Chen et al., 2018) . To examine whether Ly6C hi and Ly6C lo monocytes can differentiate into macrophages and whether cardiac fibroblasts facilitate this differentiation process, we established an in vitro co-culture system. We harvested primary cardiac fibroblasts from naive WT mice and co-cultured them with fluorescence-activated cell sorting (FACS)-sorted IL-17Ra −/− EAM splenic Ly6C hi or Ly6C lo monocytes for up to 160 h (Figure 2A ; see the sorting strategy in Figure S2A ). Due to the relative paucity of monocytes in blood, we used spleens as a surrogate source of monocytes. Flow cytometric analysis showed that approximately 80% of the Ly6C hi monocytes quickly differentiated to MDMs, while almost all Ly6C lo monocytes remained undifferentiated over the first 40 h of culture (Figures 2B and 2C) . However, when we assessed their phenotypic changes at 160 h, approximately 30% of the Ly6C lo monocytes had become macrophages (Figures 2D and 2E) . Neither Ly6C hi nor Ly6C lo monocytes were able to survival long term nor differentiate into macrophages in the absence of cardiac fibroblasts (Figures 2D and 2E) . Ly6C hi and Ly6C lo MDMs were morphologically similar and resembled macrophages after 160 h of co-culture with cardiac fibroblasts ( Figure 2F ). To better understand how monocytes and cardiac fibroblasts interact in vitro, we used livecell time-lapsed imaging to track carboxyfluorescein succinimidyl ester (CFSE)-labeled (CFSE + ) Ly6C hi and Ly6C lo monocytes co-cultured with CFSE − cardiac fibroblasts. We found that CFSE + Ly6C hi monocytes started to cluster around cardiac fibroblasts as early as 9 h into co-culture. They adhered strongly to the cardiac fibroblasts and became static when adhesions formed ( Figure 2G ; Video S1). In contrast, CFSE + Ly6C lo monocytes were motile and they formed transient clusters around cardiac fibroblasts. Ly6C lo monocytes also lost CFSE at a higher rate, indicating faster proliferation when compared to Ly6C hi monocytes ( Figure 2H ; Video S2). Flow cytometric analysis confirmed that Ly6C lo monocytes indeed proliferate faster than Ly6C hi monocytes ( Figures S2B and S2C ). Next, we used transmission electron microscopy (EM) to examine whether MDMs and cardiac fibroblasts establish cell-to-cell connections, which would suggest the presence of molecular adhesion structures. Both Ly6C hi and Ly6C lo MDMs contained numerous cytoplasmic electron-lucent vesicles (Figures 2I and 2J) . They each formed close cell-to-cell contact with cardiac fibroblasts (Figures 2K and 2L) . Interestingly, these close cell-to-cell interactions are important for driving monocyte-to-macrophage differentiation. We demonstrated a significant reduction in monocyte-to-macrophage differentiation when monocyte-fibroblast contacts are inhibited by a transwell barrier ( Figures S2D and S2E ). We also showed that Ly6C hi monocytes induced cardiac fibroblasts to significantly upregulate Ccl2 mRNA levels compared to Ly6C lo monocytes, ensuring a feed-forward loop for a continuous supply of pro-inflammatory monocytes to accumulate in an inflamed microenvironment ( Figure S2F ). Taken together, Ly6C hi and Ly6C lo monocytes establish close physical contact with cardiac fibroblasts and these cell-to-cell interactions play a role in facilitating Ly6C hi and Ly6C lo monocytes survival and differentiation into macrophages.
Inflammatory Monocytes Are the Main Precursors for MDMs during Myocarditis in Both Mice and Humans
We next sought to investigate whether both Ly6C hi and Ly6C lo monocytes could differentiate in vivo during EAM development. We FACS-sorted splenic CD45.2 + Ly6C hi or Ly6C lo monocytes from WT mice on day 14 of EAM, and intracardially injected them into CD45.1 WT recipients at the peak of EAM ( Figure 3A ). Both Ly6C hi and Ly6C lo monocytes and MDMs of the donor origin persisted in the myocardium 40 h after the injection (Figures 3B and 3C) . Approximately 50% of the injected Ly6C hi monocytes had differentiated into F4/80 hi CD64 + macrophages ( Figures 3D and 3E ), whereas less than 1% of the Ly6C lo monocytes differentiated into macrophages ( Figures 3D and 3F ). We employed Barnes-Hut stochastic neighbor embedding (bhSNE) analysis to visualize monocyte-to-macrophage differentiation (Amir et al., 2013; Becher et al., 2014) . We confirmed that CD45.2 + Ly6C lo monocytes were mostly unable to differentiate into macrophages, while CD45.2 + Ly6C hi monocytes contributed significantly to the cardiac macrophage pool during EAM (Figures 3G and 3H) . We also examined Ly6C hi and Ly6C lo monocytes differentiation at 160 h in vivo and found that very few injected monocytes were present in the myocardium, indicating a high local turnover rate. Notably, we did not find evidence suggesting Ly6C lo monocyteto-macrophage differentiation (data not shown). Upon immunofluorescence examination of endomyocardial biopsy samples from a patient with giant cell myocarditis, we found the expression of CD68, a pan-macrophage marker, coincided with CD14 but not CD16. This suggests that the inflammatory CD14 + CD16 −/+ but not the patrolling CD14 − CD16 + monocyte populations are the likely source of macrophages in giant cell myocarditis ( Figures S3A and S3B ). In parallel, we examined endomyocardial biopsies from three patients who had left ventricular assist devices implanted as a result of HF with various etiologies (Table S1 ). Flow cytometric analysis from all three patients indicated that CD14 + CD68 + , but not CD16 + CD68 + , macrophages, are present in the heart ( Figure S3C ). This further supports the hypothesis that CD14 + CD16 − monocytes are the main source of cardiac macrophages in human myocarditis. In conclusion, human CD14 + and mouse Ly6C hi monocyte subsets are the major contributors to the cardiac macrophage population during myocarditis development.
IL-17A Signaling through Cardiac Fibroblasts Inhibits Ly6C lo Monocyte-to-Macrophage Differentiation and Ly6C lo Proliferation
EAM is a Th17-driven disease and IL-17A induces the production of myelotropic cytokines and chemokines by cardiac fibroblasts (Wu et al., 2014) . The differentiation capacity of Ly6C lo monocytes in vivo appeared to be limited, and we therefore speculated that IL-17A plays a role in determining monocyte fate during EAM. Since monocytes require cardiac fibroblasts to differentiate into macrophages, we co-cultured FACS-sorted IL-17Ra −/− EAM Ly6C hi and Ly6C lo splenic monocytes with either cardiac fibroblasts alone or IL-17Astimulated cardiac fibroblasts for 160 h. We found that IL-17A-stimulated cardiac fibroblasts significantly inhibited Ly6C lo monocyte-to-macrophage differentiation, while its effect on Ly6C hi monocyte differentiation was minimal ( Figure 4A ). Using CFSE labeling, we found that proliferation of Ly6C lo monocytes was almost completely inhibited by cardiac fibroblasts stimulated with IL-17A, whereas proliferation of Ly6C hi monocytes was minimally affected ( Figure 4B ). We described previously that cardiac fibroblasts are potent producers of GM-CSF upon IL-17A stimulation (Wu et al., 2014) . We found that while treatment with recombinant GM-CSF only marginally suppressed Ly6C hi monocyte-tomacrophage differentiation ( Figure 4C ), it completely recapitulated the inhibitory effect of IL-17A through cardiac fibroblasts on Ly6C lo monocyte-to-macrophage differentiation ( Figure 4D ). IL-17A-induced inhibition of Ly6C lo monocyte-to-macrophage differentiation could be reversed with anti-GM-CSF treatment ( Figure 4D ). Similarly, GM-CSF did not change the proliferation of Ly6C hi monocytes and MDMs, while completely inhibiting proliferation of undifferentiated Ly6C lo monocytes ( Figures 4E and 4F ). Treatment of anti-GM-CSF to IL-17A-stimulated cardiac fibroblasts restored proliferation of Ly6C lo monocytes ( Figure 4F ). We further validated all of our major in vitro findings using splenic monocytes from WT animals and showed that monocytes responded to environmental cues similarly regardless of their sources ( Figure S4 ). To summarize, GM-CSF acts as a downstream mediator of IL-17A signaling, through cardiac fibroblasts, that exhibits minor inhibitory effects on Ly6C hi monocyte differentiation and proliferation, but substantially inhibits Ly6C lo monocyte differentiation and proliferation in vitro.
The Absence of IL-17A Signaling Enables Ly6C lo Monocyte-to-Macrophage Differentiation In vivo
We next aimed to test in vivo whether eliminating IL-17A signaling during EAM would enable Ly6C lo monocytes to undergo differentiation. To begin, we intracardially injected either FACS-sorted CD45.2 + Ly6C hi or Ly6C lo monocytes into CD45.1 IL17Ra −/− recipients during the peak of EAM ( Figure 5A ). Both monocyte subsets were present in the myocardium 40 h post injection ( Figures 5B and 5C ; see the monocyte gating strategy in Figure S5A ). Strikingly, while most of the Ly6C hi monocytes differentiated into macrophages, approximately 30% of the Ly6C lo monocytes also differentiated into macrophages ( Figures 5D-5F ). The bh-SNE algorithm further confirmed a non-negligible proportion of Ly6C lo MDMs ( Figures 5G and 5H ). In addition, we examined whether the Ly6C lo monocytes were able to traffic through blood and differentiate in the myocardium. We retro-orbitally injected FACS-sorted CD45.1 + Ly6C lo monocytes into either CD45.2 WT or IL17Ra −/− recipients during the peak of EAM ( Figure 5I ). CD45.1 + Ly6C lo cells were found in the myocardium 40 h post injection in both WT and IL-17Ra −/− mice compared to mice with no adoptive transferred cells (Figures 5J and 5K) . Consistent to our finding, approximately 30% of the Ly6C lo monocytes had differentiated into macrophages in IL17Ra −/− recipients but not in WT ( Figures 5L and 5M ). Therefore, our results indicate that the absence of IL-17A signaling enables Ly6C lo monocyte-to-macrophage differentiation, again, underlining the inhibitory role of IL-17A on Ly6C lo monocyte-to-macrophage differentiation.
Distinct Gene Expression Profiles in Ly6C hi and Ly6C lo MDM Subsets Differentiated In vitro in the Presence of Untreated or IL-17A-Treated Cardiac Fibroblasts
To explore the molecular differences between these MDM subpopulations, we next characterized the changes in gene expression that occurred during Ly6C lo and Ly6C hi monocyte-to-macrophage differentiation after being co-cultured with cardiac fibroblasts (conditions 1 and 2). In addition, we also examined the effect of IL-17A-stimulated cardiac fibroblasts on Ly6C hi MDMs (condition 3). Since there were very few Ly6C lo MDMs in the co-culture with IL-17A-stimulated cardiac fibroblasts, this condition was not included for this analysis. We performed microarray-based transcriptomic profiling of RNA isolated from FACS-sorted macrophages derived from the three conditions in triplicate (see the gating strategy in Figure S6A ). Gene expression profiles of the three MDM subsets were evaluated by principal-component analysis (PCA) and hierarchical clustering analysis (Figures 6A and 6B) . Both analyses demonstrated distinct gene expression profiles for the three MDM subsets, suggesting that both the microenvironment and monocyte intrinsic properties are determining factors. Differential gene expression analysis showed that consistent with both PCA and hierarchical clustering analysis, Ly6C lo MDMs versus Ly6C hi MDMs from IL-17A-treated cardiac fibroblast culture had the greatest number of differentially expressed genes (n = 1,057). Whereas Ly6C lo MDMs versus Ly6C hi MDMs from non-treated cardiac fibroblasts culture had the lowest number of differentially expressed genes (n = 644) ( Figure  S6B ). We found that IL-17A signaling through cardiac fibroblasts significantly upregulated genes encoding inflammatory chemokines, cytokines, growth factors, Il6/Stat3, and the nuclear factor κB (NFκB) pathway in Ly6C hi MDMs ( Figures 6C-6E ). Moreover, IL-17A trans-signaling through cardiac fibroblasts upregulated genes in Ly6C hi MDMs known to promote tissue fibrosis such as Osm, as well as genes related to extracellular matrix degradation including Mmp9 and Timp1 ( Figure 6F ). In contrast, Ly6C lo MDMs uniquely upregulated genes associated with class II antigen processing, including Cd74 and H2-Ab1 ( Figure 6D ). Flow cytometric analysis showed that in vitro Ly6C lo MDMs indeed expressed MHCII, strongly suggesting their antigen presentation capabilities ( Figure 6G ). Ly6C lo MDMs expressed a significantly higher level of MHCII than Ly6C hi MDMs after being injected intracardially into EAM IL17Ra −/− recipients ( Figure S6C ). Furthermore, MHCII + Ly6C lo MDMs contribute to the increased proportion of MHCII + macrophage in IL17Ra −/− mice during the resolution phase of EAM at day 28 ( Figure 6H ). We also validated that Ly6C lo MDMs do not carry a dendritic cell signature ( Figure S6D ). IL-17A signaling through cardiac fibroblasts significantly upregulated many genes encoding both M1 and M2 markers in the Ly6C hi MDMs, highlighting that the classic M1 and M2 paradigm cannot simply characterize macrophage activation complexity during disease states ( Figure S6E ) (Martinez and Gordon, 2014; Nahrendorf and Swirski, 2016) . We conclude that IL-17A trans-signaling through cardiac fibroblasts promotes pro-inflammatory and pro-tissue remodeling characteristics in Ly6C hi MDMs. Interestingly, Ly6C lo MDMs upregulate genes associated with antigen presentation and have elevated surface expression of MHCII both in vitro and in vivo. Our findings suggest that Ly6C hi and Ly6C lo MDMs represent distinct subsets that have unique roles and functions in the inflamed heart.
IL-17A Trans-Signaling through Cardiac Fibroblasts Downregulates MerTK Expression on Monocytes and MDMs
The clearance of apoptotic cells during inflammation resolution is critical for proper wound repair and tissue remodeling. The myeloid-epithelial-reproductive receptor tyrosine kinase (MerTK) is a major apoptotic cell receptor on macrophages, known to play a role in the clearance of dying cells, a process called efferocytosis (Scott et al., 2001; Zizzo et al., 2012) . Efferocytosis is also known to induce an anti-inflammatory phenotype in macrophages and diminish proinflammatory cytokine release (Bosurgi et al., 2017; Camenisch et al., 1999; Healy et al., 2016) . EM results showed engulfed apoptotic cells or large cell debris inside Ly6C hi MDMs (Figures 7A and 7B ). Their phagocytic index was significantly elevated compared to the Ly6C lo MDMs derived from the co-culture ( Figure 7C ). This indicates that Ly6C hi MDMs are professional phagocytes. Consistent with our finding that IL-17A modulates the replenishment of the tissue macrophage pool with circulating monocytes, we observed an increase in the percentage of macrophages in IL-17Ra −/− EAM hearts compared to WT EAM hearts ( Figure 7D ; see the gating strategy in Figure S7A ). In general, macrophages express considerably higher levels of MerTK than monocytes in the hearts ( Figure S7B ). We found that both monocytes and macrophages express higher levels of MerTK in IL17Ra −/− hearts compared to WT ( Figures 7E and 7F ). This suggests that IL-17A plays a role in downregulating MerTK expression on monocytes and macrophages. Furthermore, we found significantly less soluble Mer (sMer) present in IL17Ra −/− mice sera than WT animals, indicating that IL-17A might influence the rate at which MerTK is proteolytically cleaved from the surface of the cell ( Figure 7G ). In order to confirm that IL-17A signaling through cardiac fibroblasts was responsible for modulation of MerTK, we assessed MerTK expression in vitro. We confirmed that in vitro MerTK was predominantly expressed by Ly6C hi but not Ly6C lo monocytes and MDMs ( Figure 7H ). Moreover, IL-17A signaling through cardiac fibroblasts resulted in a significant downregulation of MerTK expression on Ly6C hi monocytes and MDMs ( Figure 7H ). In addition, we observed that sMer was significantly elevated in the co-culture supernatants when IL-17A signaling was present ( Figure 7I ). Our findings suggest that IL-17A-stimulated cardiac fibroblasts can suppress macrophages' phagocytic function by promoting MerTK cleavage, resulting in reduced surface MerTK expression. Our results also suggest that Ly6C hi MDMs in WT EAM hearts have compromised phagocytic activities during heart inflammation. We retroorbitally injected fluorescein isothiocyanate (FITC)-conjugated latex beads in both IL17Ra −/− and WT EAM mice. We found significantly more FITC + macrophages in the hearts of IL17Ra −/− compared to WT, indicating enhanced phagocytic activity in an IL-17Asignaling-deficient environment (Figures 7J and 7K ). Human myocarditis patients were reported to have high serum IL-17A, as well as an abundant presence of Th17 cells in their hearts and blood (Myers et al., 2016) . Indeed, we found higher frequencies of IL-17A expressing infiltrating leukocytes in the hearts of myocarditis patients compared to patients with ischemic cardiomyopathy (Figures S7C and S7D ; Tables S2 and S3 ). We therefore hypothesized that myocarditis patients could have lower MerTK expression in their cardiac myeloid population. In a cohort of HF patients, we found a significant reduction in myeloid MerTK expression in patients with myocarditis as compared to those with ischemic HF, similar to our finding in a murine model ( Figure 7L ; Tables S2 and S3 ). In conclusion, IL-17A signals through cardiac fibroblasts to promote MerTK cleavage on Ly6C hi MDMs, thus compromising the processes of efferocytosis. With reduced phagocytic ability as a result of surface MerTK modulation, we predict that macrophages are less efficient in clearing apoptotic cells efficiently and more likely to exhibit a proinflammatory phenotype, which in turn could promote irreversible cardiac remodeling and fibrosis.
DISCUSSION
Monocytes and macrophages are key effector cells in the injured myocardium during human myocarditis and EAM (Barin et al., 2012; Theaker et al., 1985) . Although both Ly6C hi and Ly6C lo monocytes infiltrate the myocardium during EAM, we found that an excessive accumulation of Ly6C hi rather than Ly6C lo monocytes in the heart leads to adverse cardiac remodeling and the development of DCM (Wu et al., 2014) . However, it was unknown whether both infiltrating Ly6C hi and Ly6C lo monocytes contribute to the adverse cardiac tissue remodeling during development of EAM. Moreover, the role of the local proinflammatory cardiac microenvironment in influencing Ly6C hi and Ly6C lo monocyte fate and function was not well understood. We used three fate-mapping strategies to evaluate the phenotypic and functional changes of monocytes in the heart during myocarditis: parabiosis, adoptive transfer of monocytes, and an in vitro co-culture system.
Under steady state, adult cardiac tissue macrophages in mice are of mixed embryonic and hematopoietic origins Hashimoto et al., 2013; Hoeffel et al., 2015; Schulz et al., 2012; Sheng et al., 2015) . In cases of aging or perturbed homeostasis, a greater proportion of embryonic-derived macrophages are replaced by infiltrating monocytes, changing the landscape of macrophage dynamics in the heart. Heidt et al., 2014; Molawi et al., 2014) . Our parabiosis fate-mapping results reveal that monocytes extravasate into hearts during EAM and readily differentiate into macrophages, which contributes to the increase in the cardiac macrophage number during EAM. It was previously reported that cardiac CCR2 − macrophages, including MHCII + and MHCII − populations, are largely embryonically derived, whereas cardiac CCR2 + macrophages represent a hematopoietically derived lineage at steady state . Embryonically derived macrophages are shown to have regenerative and reparative properties (Aurora et al., 2014; Lavine et al., 2014) , whereas CCR2 + macrophages are thought to initiate inflammation and contribute to adverse cardiac remodeling (Bajpai et al., 2018; Li et al., 2016) . We report here that infiltrating monocytes predominantly contribute to the CCR2 + MHCII + macrophage compartment. Albeit to a lesser extent, they are also able to differentiate into CCR2 − MHCII + macrophages, with very few becoming CCR2 − MHCII − macrophages in the chronically inflamed heart.
Ly6C hi monocytes are known to replenish the macrophage pool during cardiac injury; however, the contribution of Ly6C lo monocytes to the cardiac macrophage pool has not been previously described (Bronte and Pittet, 2013; Dutta et al., 2012; Leuschner et al., 2012; Robbins et al., 2012; Epelman et al., 2014; Heidt et al., 2014; Hilgendorf et al., 2014; Nahrendorf et al., 2007) . Here, we show that both Ly6C hi and Ly6C lo monocytes have the capability to differentiate into macrophages, a process driven by direct contact with cardiac fibroblasts. Previously, we demonstrated that IL-17A can stimulate cardiac fibroblasts to produce significant amounts of GM-CSF (Wu et al., 2014) . Evidence from EAM, Kawasaki syndrome, and the mouse model of MI show that cardiac fibroblasts are potent producers of GM-CSF (Anzai et al., 2017; Chen et al., 2018; Stock et al., 2016; Wu et al., 2014) . An accumulating body of literature indicates that GM-CSF plays a key role in signaling myelopoiesis in response to tissue injury. GM-CSF also induces a pathogenic transcriptional signature in pro-inflammatory monocytes propelling the inflammatory cascade, resulting in further tissue damage (Anzai et al., 2017; Croxford et al., 2015; Wu et al., 2014) . Here, we show a profound inhibitory role of IL-17A as it works in trans through cardiac fibroblastderived GM-CSF on Ly6C lo monocyte-to-macrophage differentiation in vitro.
Other studies have implemented Ly6C lo latex bead labeling methods to track Ly6C lo monocytes in vivo (Potteaux et al., 2011; Tacke et al., 2007) . However, due to the inadequate labeling efficiency in the EAM model, we were unable to distinguish and quantify Ly6C lo MDMs in EAM hearts using this method (data not shown). Alternatively, we used both intracardial and retro-orbital adoptive transfer methods and confirmed in vivo the inhibitory effect of IL-17A signaling on Ly6C lo monocyte-to-macrophage differentiation. We hypothesize that these Ly6C lo MDMs have distinct functions in myocarditis compared to Ly6C hi MDMs.
Gene expression profiling results substantiate that Ly6C hi and Ly6C lo MDMs represent distinct cell types, possibly driven partly by intrinsic properties. Recent studies have demonstrated that Ly6C hi and Ly6C lo monocytes are phenotypically heterogenous populations. Intrinsic properties such as transcription factors regulate Ly6C hi and Ly6C lo monocyte fate and function during steady state or tissue injury (Menezes et al., 2016; Yanez et al., 2017; Ikeda et al., 2018; Satoh et al., 2017; Mildner et al., 2017) . However, we found that IL-17A signaling through cardiac fibroblasts accentuates a pro-inflammatory and protissue remodeling gene profile in Ly6C hi MDMs. These macrophages upregulate genes such as Il6, Mmp9, Timp1, and Osm, all of which have been implicated in cardiac dysfunction and maladaptive cardiac remodeling (Hansson et al., 2011; Heymans et al., 2005; Hirota et al., 2004; Kubin et al., 2011; Kubota et al., 2000; Morishita et al., 2017) . Unexpectedly, we found that Ly6C lo MDMs are enriched with genes associated with class II antigen processing. We confirm that Ly6C lo MDMs express higher levels of MHCII than their Ly6C hi counterparts in vitro. IL17Ra −/− mice develop EAM similarly to their WT counterparts, but are protected from DCM, cardiac fibrosis, and dysfunction (Baldeviano et al., 2010) . In vivo, IL17Ra −/− EAM hearts contain more MHCII + macrophages than WT EAM controls during disease resolution, coinciding with DCM protection in IL17Ra −/− mice. The anti-inflammatory and proangiogenic properties of Ly6C lo monocytes were previously investigated, and their roles in the resolution of cardiac inflammation were frequently highlighted (Hilgendorf et al., 2014; Nahrendorf et al., 2007; Wu et al., 2014) . This suggests that MHCII + Ly6C lo MDMs might be beneficial in disease resolution and contribute to the protection of IL17Ra −/− mice from DCM and HF. The functions of Ly6C lo MDMs were placed under scrutiny recently. It has been implicated that they are the precursors for wound-healing macrophages in a soft tissue injury model (Olingy et al., 2017) . Paradoxically, they were also shown to give rise to inflammatory macrophages in an autoimmune arthritis model (Misharin et al., 2014) . We offer clues that Ly6C lo MDMs are a non-inflammatory and non-tissue-remodeling population. The increased presence of these macrophages and an increased Ly6C lo -to-Ly6C hi ratio in EAM myocardium correlate with DCM protection in IL17Ra −/− mice (Wu et al., 2014) . Although phagocytic activity of Ly6C lo MDMs is unremarkable, their potential antigen presentation capability predicts their immune regulatory role in the heart. Whether MHCII + Ly6C lo MDMs play a role in effector and/or memory T cell or regulatory T cell activation in the heart requires further examination. Recent evidence indicated that MHCII + macrophages loaded with cardiac myosin peptide are not effective in stimulating the proliferation of autoreactive CD4 + T cells (Anzai et al., 2019) . However, the beneficial effects of macrophages and regulatory T cell interactions during inflammation resolution and tissue regeneration have been reported (Panduro et al., 2018; Proto et al., 2018) . Currently, it remains unfeasible to selectively deplete Ly6C lo monocytes in mice. However, further experiments utilizing Nr4a1 −/− , CX3CR1 −/− , or S1PR5 −/− mice with reduced Ly6C lo monocytes can help to better assess the specific functional role of Ly6C lo monocytes-derived macrophage in the context of myocarditis (Debien et al., 2013; Hanna et al., 2011; Landsman et al., 2009) .
Macrophage function can be shaped by both progenitor origin and tissue microenvironment (Amit et al., 2016; Lavine et al., 2014) . We tested the hypothesis that upon IL-17A stimulation, cardiac fibroblasts play a role in modulating macrophage function. Recent data directly link the level of efferocytosis receptors on monocytes and macrophages to phagocytosis-dependent wound healing and restoration of organ function (Foo et al., 2005; Whelan et al., 2010; Howangyin et al., 2016; Wan et al., 2013) . Uncontrolled cellular necrosis and apoptosis during cardiac injury are integral components that contribute to adverse tissue healing and remodeling. Inefficient phagocytic clearance can also lead to exposure of self-antigens, which contribute further to autoimmune reactivity (Wermeling et al., 2009) . One of these efferocytosis receptors, MerTK, has been shown to be upregulated on phagocytic cells during inflammation and plays an essential role in apoptotic cell recognition and clearance (Chen et al., 1997; Hilliard et al., 2014; Scott et al., 2001; Seitz et al., 2007) . Moreover, efferocytosis triggers a shift in macrophage activation, making them phenotypically less proinflammatory (Camenisch et al., 1999; Fadok et al., 1998; Healy et al., 2016) . Notably, our in vivo and in vitro results suggest that IL-17A signaling through cardiac fibroblasts leads to MerTK shedding and the release of sMer, which significantly reduces surface MerTK expression on Ly6C hi monocytes and MDMs. Cardiomyocytes have been shown to induce shedding of macrophage MerTK to suppress phagocytosis . This highlights another mechanism by which IL-17A through cardiac fibroblasts can induce MerTK shedding and, in turn, contributes to cardiac pathology in autoimmune myocarditis. Moreover, we showed that myeloid MerTK was significantly lower in human myocarditis patients when compared to ischemic patients. These findings warrant future studies to determine whether sMer can be used as a biomarker in clinical settings to differentiate patients with myocarditis from those with other types of cardiac diseases.
Taken together, we underscore the fates of Ly6C hi and Ly6C lo monocyte subsets as a result of changes in the cardiac microenvironment. We demonstrate how the local cardiac milieu instructs cardiac fibroblasts to facilitate monocyte differentiation and proliferation as well as to regulate the phenotype and function of monocytes and MDMs. Monocytes are versatile immune cells playing a multi-faceted role in a wide range of inflammatory disorders (Arnold et al., 2007; Misharin et al., 2017; Mishra et al., 2012; Nahrendorf et al., 2007; Olingy et al., 2017; Rahman et al., 2017) . Our findings have broader implications for inflammatory diseases in the heart and other organs. We recently reported that IL-17A signaling to cardiac fibroblasts is associated with severe fibrosis and post-infarct death (Chen et al., 2018) , which demonstrates a potential parallel concept that warrants future investigation. Ultimately, we anticipate that further studies of macrophage-cardiac fibroblast interactions will provide valuable insights into the development of targeted therapies that prevent deleterious inflammatory responses.
STAR⋆METHODS LEAD CONTACT AND MATERIALS AVAILABILITY
Requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Daniela Ciháková (cihakova@jhmi.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Patients-Left ventricle apex endomyocardial biopsies were obtained from patients with end stage heart failure (AHA stage D) of various etiologies. These patients were undergoing either an implantation of Left Ventricular Assist Device (LVAD), or an orthotopic heart transplant after LVAD explant at the Texas Heart Institute. Details including patients' age and gender are summarized in Table S1 -3. Informed consent was obtained from human subjects and the study protocol was approved by the Committee for the Protection of Human Subjects (University of Texas Health Science Center at Houston. IRB #HSC-MS-05-0074). Samples were properly preserved in cryovials embedded in liquid nitrogen (−190°C) and then kept at −80°C in the tissue bank at the Texas Heart Institute, Houston, TX as previously described (Razeghi et al., 2001) . Aliquots of the samples were shipped frozen and processed in house. Reported diagnoses corresponded to clinical charts, based on standard histology (H&E), clinical presentation, hemodynamic parameters, and routine clinical biochemical and serology parameters. Patient's information of all samples was processed with random non-linked code relabeling in a database at the time of preservation. Furthermore, for each sample, a separate random non-linked code was assigned for the analysis process. Separately, one paraffin embedded, virus negative, acute giant cell myocarditis left ventricle transmural endomyocardial biopsy sample in Figures S3A and S3B were provided by Dr. Karin Klingel. The sample was taken for routine diagnostic purposes to identify infectious agents in the myocardium as described before (Zuern et al., 2013) . Informed consent was obtained and the study was approved by local ethic committee (Project-No.253/2009BO2) . Diagnosis of giant cell myocarditis was based on established criteria (Caforio et al., 2013b) .
Mice-IL-17Ra -/mice on BALB/c background were provided by Amgen Inc. (Thousand Oaks, CA) and Dr. J. Kolls (Children's Hospital, University of Pittsburgh Medical Center, Pittsburgh, PA) (Wu et al., 2014; Yu et al., 2008) . CByJ.SJL(B6)-Ptprc a /J (CD45.1) mice (006584) and WT BALB/cJ (000651) mice were purchased from The Jackson Laboratory.
IL-17Ra -/mice were crossed to CByJ.SJL(B6)-Ptprc a /J (CD45.1) mice and bred to homozygosity at both loci. All mice were housed and maintained in the Johns Hopkins University School of Medicine specific pathogen-free vivarium. 6 -10 weeks old healthy naive male mice were randomly selected as the subjects of all of our studies. All experiments involving animals were in compliance with the Animal Welfare Act and strictly followed the Guide for the Care and Use of Laboratory Animals. The Animal Care and Use Committee of The Johns Hopkins University has approved all procedures and protocols used in this study.
Primary Adult Cardiac Fibroblasts Isolation and Culture-50U heparin was injected i.p. into 6 -10-week-old male BALB/cJ naive mice prior to sacrifice. Hearts were cannulated through the aorta and perfused for 3 minutes with 37°C perfusion buffer at 4 mL/ minute: 7.03 g/L NaCl, 1.1 g/L KCl, 0.082 g/L KH 2 PO 4 , 0.085 g/L Na 2 HPO 4 , 0.144 g/L MgSO 4 , 2.38 g/L HEPES, 0.39 g/L NaHCO 3 , 1 g/L glucose, 3.74 g/L Taurine, 1 g/L 2,3-Butanedione monoxime (all Sigma), and for 8 min with Collagenase II and Protease XIV (Worthington) and 0.03M CaCl 2 . Hearts were cut into small pieces and cells separated by gently pipetting for 3 minutes or until no large tissue pieces were observed. Cells were filtered through a 100 mm filter and washed in DMEM (GIBCO). Cells were plated in DMEM with 20% FBS (GE Healthcare Life Sciences), nonessential amino acids (Sigma), Penicillin/Streptomycin, 2 mM L-Glutamine, and 25mM HEPES (all Quality Biological). Cells were incubated in a humidified 5% CO 2 incubator at 37°C from here on. Non-adherent cells were washed away after 1 hour. Fibroblasts from second passage were used in experiments. The purity of cardiac fibroblast cultures was confirmed by qPCR and flow cytometry. Cells and supernatants were harvested at the indicated time points after addition of recombinant mouse cytokine IL-17A at 50 ng/mL or recombinant mouse GM-CSF at 50ng/mL (Peprotech). LEAF™ Purified anti-GM-CSF at 50μg/mL was used (MP1-22E9, BioLegend). Monocytes and fibroblasts separation in the co-culture was achieved by 0.4 μM transwell inserts (Corning).
METHOD DETAILS
Parabiosis Surgery-Pairs of mice were anesthetized by isoflurane inhalation, 4.0-5.0% v/v induction (Baxter). Fur was removed thoroughly from the entire flank region using clippers. Anesthesia in surgical pairs was maintained with intramuscular injections of ketamine (80 mg/kg) and xylazine (16 mg/kg). The mice were laid supine and the site was disinfected with betadine followed by 70% EtOH. We administered buprenorphine (0.1 mg/kg) intraperitoneally for the initial analgesia, and at 12 hours postoperatively. Longitudinal incisions were made through the skin starting from the elbow joint and extended down to the knee joint. Non-absorbable 4-0 interrupted sutures were placed around the knee and elbow joints. Pairs where attached from the elbow joints first. To increase skin anastomosis, we used a continuous 5-0 absorbable vicryl sutures through the muscular layer and connect the pairs further, before attaching the knee joints. Surgical stapler was used to connect the skins of the pairs. Baytril was used upon completion of the procedure. Animals were provided with moistened chow and gel food diet supplement every other day until sacrifice at 19 to 20 days after parabiosis.
EAM Induction-To induce EAM, we injected mice with 125 μg myosin heavy chain α peptide MyHCα 614-629 (Ac-SLKLMATLFSTYASAD; Genscript) (Pummerer et al., 1996) emulsified in CFA (Sigma-Aldrich) supplemented with 5mg/mL heat-killed Mycobacterium tuberculosis strain H37Ra (Difco) on days 0 and 7. On the first day of immunization, mice also received a dose of 500 ng pertussis toxins intraperitoneally (List Biological Laboratories) (Ciháková et al., 2004) .
EAM Histopathology Assessments-Myocarditis severity was evaluated by histology on days 21. Heart tissues were fixed in SafeFix solution (Thermo Fisher Scientific), embedded and cut into 5 μm serial sections. Sections were stained with H&E and ventricular inflammation was scored via a microscope by two independent blinded investigators and averaged using the following criteria for hematopoietic infiltrates: grade 0, no inflammation; grade 1, < 10% of the heart section is involved; grade 2, 10%-30%; grade 3, 30%-50%; grade 4, 50%-90%; grade 5, > 90% (Ciháková et al., 2004) .
Isolation of Splenic Ly6C hi and Ly6C lo Monocytes-Spleens from WT or
IL-17Ra -/-BALB/c mice on day 14 of EAM were dissected and mechanically disrupted. Cells were filtered through 40 mm cell strainers and washed. Histopaque 1119 and 1077 (Sigma) were used to isolate mononuclear cells. Anti-Ly6G MicroBead kit (Miltenyi Biotech) was used to deplete Ly6G + cells, and CD11b MicroBead kit (Miltenyi Biotech) was used to positively enrich CD11b + cells. Cells were sorted on an AriaIIu cell sorter. Sorted cells from IL-17Ra -/-BALB/c mice spleens were used for in vitro co-culture with primary cardiac fibroblasts, major outcomes were validated with sorted cells from WT BALB/c mice spleens co-cultured with cardiac fibroblasts. Sorted cells from WT BALB/c mice spleens were used in adoptive transfer experiments (see below).
Cell Staining and Light Microscopy-Modified
Giemsa staining was achieved by using Differential Quik Stain Kit, following the manufacturer's instructions (Polysciences). Cell staining images were acquired on Olympus BX43 microscope with a camera (DP72) using cellSens Standard software (version 1.4.1; Olympus).
IncuCyte ZOOM Imaging-Once the monocyte-fibroblast co-cultures were established, the plates were placed into the IncuCyte ZOOM™ (Essen Bioscience) apparatus and images of cells were recorded with 20 × magnification undisturbed every 1 hour for a total duration of 160 hours. Cardiac fibroblasts alone were used as controls and triplicated wells were included in all data acquisitions.
Transmission Electron Microscopy-Co-cultured cells were washed with 1 × PBS and fixed in 2.5% glutaraldehyde dissolved in 0.1 M Na cacodylate. Samples were then processed by the Johns Hopkins Microscope Facility (Diny et al., 2017) before examination using the Philips CM120 transmission electron microscope. Images were captured using Advanced Microscopy Techniques V602 software. The phagocytic index was calculated according to the following formula: phagocytic index = (total number of engulfed cells/total number of counted macrophages) × (number of macrophages containing engulfed cells/total number of counted macrophages) × 100. Approximately 60 total macrophages derived from each monocyte subset were counted, numbers were acquired from two separate assessments.
Immunofluorescence Microscopy-Human paraffin-embedded giant cell myocarditis biopsy sample slides were processed using xylene and rehydrated with decreasing concentration of ethyl alcohol and rinsed with distilled water. After blocking with 1% BSA and 0.1% tween-20 in 1 × PBS, tissues were incubated with anti-CD14-biotin sheep antibodies (R & D systems) and anti-CD68 mouse antibodies (Abcam). We then used NL-637 Streptavidin and donkey NL-557 anti-mouse IgG (R & D systems) as secondary antibodies diluted in 0.05% Evans Blue for counterstaining. DAPI was used for staining nuclei. Finally, Sudan Black was used to suppress auto-fluorescence as a result of tissue fixation and paraffin treatment. Images were acquired using Zeiss Axio Imager.A2 microscope with AxioCam MRm at 20 × magnification. We used AxioVision Rel. 4.8 software to acquire images and Adobe Photoshop CC to process images.
Intracardiac Injection-WT or IL-17Ra -/-BALB/c mice on day 21 of EAM were depilated and anesthetized with 3.5% isoflurane (Baxter). The mice were subsequently endotracheally intubated, 100% oxygen and 2% isoflurane were provided to the animals throughout the operation by mechanical ventilation (Model 845, Harvard Apparatus). Preoperational analgesics (0.05 mg/kg Buprenorphine, Reckitt Benckiser) and paralytics (1 mg/kg Succinylcholine, Henry Schein) were administered prior to operation. Mice were subjected to a thoracotomy, typically around the 4th or 5th intercostal space to expose the heart ventricles. Roughly 1.5 -2 × 10 5 cells were injected with a 29G 29G ½ insulin syringe (BD) into 2 -3 ventricular locations. Mice were placed under the heat lamp to recover postsurgery, post-operational analgesics (0.05 mg/kg Buprenorphine, Reckitt Benckiser) were administered. Mice were sacrifice at 40 hours or at 160 hours post-surgery to assess cell transfer outcomes.
Retro-Orbital Injection of Monocytes-WT or IL-17Ra -/-BALB/c mice on day 21 of EAM were depilated and anesthetized with 100% oxygen and 3.5% isoflurane (Baxter). Mice were subjected to an injection into the ophthalmic venous sinus. Roughly 4 -5 × 10 5 FACS sorted monocytes were injected with a 29G ½ insulin syringe (BD).
Retro-Orbital Injection of Liposomes and Latex Beads-
We administered a single treatment of 10 μl Clodrosome (clodronate loaded liposomes; Encapsula Nano Sciences) per gram of animal weight seventeen hours prior to latex microsphere labeling to better visualize FITC + macrophages in vivo. 0.5-μm FITC-conjugated (yellow gold) plain microspheres (2.5% solids [wt/vol]; Polysciences, Inc.) were diluted 1:25 in 1XPBS. We administered 250 μl of the diluted latex beads to examine macrophage phagocytic activity in vivo. Hearts were harvested 24 hours post bead administration.
Quantitative Reverse Transcription PCR-Cell mRNAs were extracted in TRIzol (Invitrogen), and reverse transcribed using High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems). Target cDNAs were amplified with Power SYBR Green PCR Master Mix (Bio-Rad) and real time cycle thresholds were detected via MyiQ2 themocycler running on an iQ5 software (Bio-Rad). Target genes fold induction were calculated using the 2 −ΔΔCt method by normalizing cycle thresholds to the Hprt housekeeping gene and medium controls (Livak and Schmittgen, 2001) . Verified Ccl2 primer sequences were acquired from the PrimerBank (Harvard Medical School, Massachusetts General Hospital and The Center for Computational and Integrative Biology), and commercially synthesized (Integrated DNA Technologies). Ccl2 forward primer sequence (5′ to 3′):
TTAAAAACCTGGATCGGAACCAA, and reverse primer sequence (5′ to 3′): GCATTAGCTTCAGATTTACGGGT.
Flow Cytometry Analysis and Barnes-Hut Stochastic Neighbor Embedding
Analysis-Hearts of naive or EAM mice were perfused through the ventricles with 1 × PBS for 3 minutes. GentleMACS C Tubes were used to mechanically disassociate the tissue according to manufacturer's instructions (Miltenyi Biotech). We used 3000 U Collagenase II and 300 U DNase I (Worthington) dissolved in 5mL HBSS to digest tissue and obtain single cell suspension. Splenocytes, blood, and BM cells (femurs and tibias) were isolated by mechanical disruption, followed by red blood cell lysis using ACK buffer (ThermoFisher). Heart samples were filtered through 40 μm filters, whereas the other tissues were filtered through 70 μm filters. Single-cell suspensions were stained with LIVE/DEAD Fixable Far Red Dead Cell Stain Kit (ThermoFisher), washed, FcγRII/III blocked with a-CD16/CD32, and stained with fluorochrome-conjugated antibodies (eBioscience, BioLegend, BD PharMingen). Alternatively, we used APC Annexin V Apoptosis Detection Kit with 7-AAD (BioLegend) instead of LIVE/DEAD. CellTrace™ CFSE Kit was used to track cell proliferation both in vivo and in vitro (ThermoFisher). Samples were acquired on a BD LSRII or LSRFortessa 4-laser cytometers running FACSDiva 6.0 (BD Immunocytometry) and analyzed using FlowJo 10.4 software. We ran an interactive visualization tool called cyt in MATLAB to analyze high-dimensional flow cytometry data (Becher et al., 2014; Amir et al., 2013) . bh-SNE is an unsupervised non-linear dimensionality reduction embedding technique (Amir et al., 2013) .
Microarray-Ly6C hi and Ly6C lo in vitro co-culture derived macrophages in triplicate were FACS sorted and cells were lysed using RLT buffer (QIAGEN). RNA was extracted using RNeasy micro kit. RNA samples were labeled using Thermal Fisher 3′ IVT Pico Reagent kit (Affymetrix) according to manufacturer's guidelines and probed using the Affymetrix Mouse Clariom S Array. RNA concentration and integrity were determined with Agilent Bioanalyzer Pico Chip.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical Analysis-GraphPad Prism 7 software was used for statistical analysis. Statistical analysis details are described in the figure legends. To determine if datasets show a normal distribution, either the D'Agostino-Pearson or the Shapiro-Wilk normality test was used. P values were considered statistically significant at p < 0.05. All data were presented as mean ± SD.
DATA AND CODE AVAILABILITY
Microarray Gene Expression Analysis-Raw data generated from Clariom S Arrays were processed using Affymetrix Expression Console Software. CEL files containing feature intensity values were converted into summarized expression values by Partek Genomic Suite Software including background adjustment, quantile normalization and summarization across all chips. All samples passed QC thresholds for hybridization, labeling and the expression of spiked in controls. The variances, both between and within groups, in log2 transformed expression values were analyzed by one-way ANOVA. PCA graph was generated using Partek Genomic Suite Software, heatmaps were generated using TIBCO Spotfire Software. The complete normalized dataset is available on GEO: GSE118861. Figure S1 . Figure S3 and Table S1 . (D) . (C and D) Data are representative of three independent experiments with technical triplicates. n = 3. Groups were compared using one-way ANOVA followed by Dunnett test. *p < 0.05; ****p < 0.0001. All data were presented as mean ± SD. See also Figure S4 . 
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